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Age, yrs 62.710.1
Male 353 (79)
Hypertension 273 (61)
Diabetes mellitus 143 (32)
Smoking 192 (43)
Hyperlipidemia 317 (71)
Chronic renal failure 35 (7.9)
Previous myocardial infarction 107 (24)
Impaired LV function (EF<30%) 5 (1.1)
Multi-vessel 241 (54)
Previous CABG 9 (2.2)
Adenosine (route)
Intracoronary 63 (14)
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BACKGROUND Fractional ﬂow reserve (FFR) invasively assesses the
ischemic potential of coronary stenosis and predicts the expected
improvement achievable by revascularization. A FFR value of 0.75
has been validated against ischemic testing, while a FFR value of
0.80 has been widely accepted to guide clinical decision making.
Whether, and in which patients revascularization should be pro-
posed when the FFR is between 0.76-0.80 “gray zone” is still
debatable. Therefore, we studied the clinical outcome of patients
with an isolated stenosis and an FFR value in and around the gray
zone.
METHODS From February 1997 to June 2013, all patients presenting
with single segment disease at coronary angiography and FFR within
the gray zone of 0.76-0.80 and in the neighbored strata of 0.70-0.75
and 0.81-0.85 were included. Patients with previous bypass surgery,
in-stent restenosis, myocardial bridge, or heart transplantation were
excluded. According to FFR values, patients were divided into the
following strata: a) 0.70-0.75; b) 0.76-0.80; c) 0.81-0.85. Study end-
points consisted of major adverse cardiovascular events (MACE:
death, myocardial infarction and any revascularization) up to 5 years.
Data were also analyzed according to their lesion location (proximal
versus distal).
RESULTS Out of 17380 patients undergoing FFR measurement: a)
overall FFR values were within the gray zone in 2781 (16%) of cases;
b) 1459 fulﬁlled the inclusion/exclusion criteria and were included
in the present analysis: 449 treated with revascularization (revasc)
and 1010 with medical therapy (MT). Clinical characteristics were
similar among patients treated with revascularization or MT, except
for male gender and age (more frequent in PCI group respectively
[p¼0.002] and [p¼0.05]). Diameter stenosis, minimum lumen
diameter, and FFR values were lower in revasc group (p<0.0001). In
patients with an FFR between 0.70 and 0.75, MACE’s were more
frequent after MT than after revasc (12 [23%] vs. 57 [13%], respec-
tively, p¼0.046). In patients with an FFR between 0.81 and 0.85,
MACE’s were less frequent after MT than after revasc (59 [8%] vs.
57 [13%], respectively, p¼0.023). Among patients treated with MT
alone, a progressive increase in MACE was observed in the 3 FFR
strata (FFR, 0.70-0.75: 12 [23%] vs. FFR, 0.76-0.80: 37 [14%] vs.
FFR, 0.81-0.85: 59 [8%], p<0.001). For stenoses located only in
proximal segments, decreasing FFR values were parallelled by an
increase MACE and in overall mortality (respectively p<0,001 and
p¼0.017).
CONCLUSIONS Patients with stenosis located in the proximal coro-
nary segments and FFR in the gray zone of 0.76-0.80 demonstrate a
MACE rate that is intermediate compared with that of patients  0.75
ischemic threshold and above the 0.80 clinical threshold. These data
suggest that an FFR  0.80 is valid to guide clinical decision making
with lesion located in proximal coronary segments, while distal cor-
onary stenosis with FFR in the gray zone might be safely deferred to
MT.
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BACKGROUND Clinically tolerated levels of measurement drift
(2mmHg) can affect the diagnostic accuracy of pressure-only indices
of stenosis severity. This real world consideration has not formally
been assessed for FFR, iFR and whole cycle Pd/Pa indices. The
objective of this study was to quantify the effect of measurement drift
on stenosis misclassiﬁcation with FFR, iFR and whole cycle Pd/Pa
indices.
METHODS Haemodynamic pressure traces from 447 stenoses (447
patients) were assessed with FFR, iFR and whole cycle Pd/Pa indices.
Cut point values for signiﬁcance were 0.8, <0.90 and <0.93
respectively. Measurement drift was simulated by offsetting the distal
intracoronary pressure trace by 2mmHg. FFR, iFR and whole cycle
Pd/Pa indices were recalculated and the impact upon stenosis classi-
ﬁcation quantiﬁed.
RESULTS Median (median absolute deviation) values for FFR, iFR
and whole cycle Pd/Pa medians were 0.81 (0.11), 0.90 (0.07), and
0.93 (0.06) respectively. The dynamic range of values for each index
was different. iFR had the largest dynamic range of values (95% range:
0.39 – 1.0, a 62 unit spread), compared to FFR (95% range: 0.43 – 0.97,
a 55 unit spread) and resting whole cycle Pd/Pa (95% range: 0.59 – 1.0,
a 41 unit spread) (p<0.001 for all comparisons). Stenosis misclassiﬁ-
cation occurred with all three indices. Both FFR and iFR had signiﬁ-
cantly lower proportions of misclassiﬁcation than whole cycle Pd/Pa
(p<0.001). There was no statistically signiﬁcant difference between
the diagnostic performance of FFR and iFR indices (p¼0.125). Overall,
21% (94), 25% (110) and 33% (148) of the total study population were
inappropriately misclassiﬁed with FFR, iFR and whole cycle Pd/Pa
respectively.
